Association of liver enzymes with incident type 2 diabetes: A nested case control study in an Iranian population
Open Access
- 5 June 2008
- journal article
- research article
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 8 (1) , 5
Abstract
Background: To investigate the association of Aspartate aminotransferase (AST), Alanin aminotranferase (ALT) and Gamma glutamyl transferase (GGT) with incident type 2 diabetes. Methods: In a nested case-control study, AST, ALT, GGT as well as classic diabetes risk factors, insulin and C-reactive protein (CRP) were measured in 133 non-diabetic subjects at baseline of which 68 were cases and 65 were controls. Incident diabetes was defined by the WHO 1999 criteria. Conditional logistic regression was used to calculate the odds ratio (OR) of incident diabetes associated with different hepatic markers. We used factor analysis for clustering of classic diabetes risk factors. Results: In Univariate analysis both ALT and GGT were associated with diabetes with ORs of 3.07(1.21–7.79) and 2.91(1.29–6.53) respectively. After adjustment for CRP and insulin, ALT and GGT were still predictive of incident diabetes. When the model was further adjusted for anthropometric, blood pressure and metabolic factors, only ALT was independently associated with diabetes [OR = 3.18 (1.02–9.86)]. No difference was found between the area under the receiver operating characteristic curves of the models with and without ALT (0.820 and 0.802 respectively, P = 0.4) Conclusion: ALT is associated with incident type 2 diabetes independent of classic risk factors. However, its addition to the classic risk factors does not improve the prediction of diabetes.Keywords
This publication has 28 references indexed in Scilit:
- Alanine aminotransferase as a marker of non‐alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular diseaseDiabetes/Metabolism Research and Reviews, 2006
- Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up studyDiabetes & Metabolism, 2005
- Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older MenDiabetes Care, 2005
- Serum γ-Glutamyltransferase and Risk of Metabolic Syndrome and Type 2 Diabetes in Middle-Aged Japanese MenDiabetes Care, 2004
- Is Oxidative Stress the Pathogenic Mechanism Underlying Insulin Resistance, Diabetes, and Cardiovascular Disease? The Common Soil Hypothesis RevisitedArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic SyndromeHepatology, 2003
- Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (Phase 1)International Journal of Public Health, 2002
- High Alanine Aminotransferase Is Associated With Decreased Hepatic Insulin Sensitivity and Predicts the Development of Type 2 DiabetesDiabetes, 2002
- Non‐alcoholic fatty liver diseaseJournal of Gastroenterology and Hepatology, 2002
- Prospective Study of Serum γ-Glutamyltransferase and Risk of NIDDMDiabetes Care, 1998